Adam C. Palmer

Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy

Adam C. Palmer, Peter K. Sorger · Cell · 2017 · 638 citations · Full text

Drug Additivity, Oncology, Cancer Management +7

Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes

Adam C. Palmer, Erdal Toprak, Michael Baym et al. · Nature Communications · 2015 · 170 citations · Full text

Opposing effects of target overexpression reveal drug mechanisms

Adam C. Palmer, Roy Kishony · Nature Communications · 2014 · 147 citations · Full text

Drug Target, Medicine, Mechanism Of Action +4

A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity

Adam C. Palmer, Christopher Chidley, Peter K. Sorger · eLife · 2019 · 136 citations · Full text

Drug Additivity, High Fractional Cell, Curative Cancer Therapies +14

A Mathematical Model for Transcriptional Interference by RNA Polymerase Traffic in Escherichia coli

Kim Sneppen, Ian B. Dodd, Keith E. Shearwin et al. · Journal of Molecular Biology · 2004 · 119 citations

Rna Polymerase Traffic, Natural Sciences, Molecular Biological Method +11